Clinical Trials
ESGO 2026: Elenagen Phase II Data in Platinum-Resistant OC

ESGO 2026: Elenagen Phase II Data in Platinum-Resistant OC

At the 2026 Congress of the European Society of Gynaecological Oncology (ESGO) in Copenhagen, Dr Gabriel Levin of the McGill University Health Centre will present Phase II data evaluating the investigational DNA therapy Elenagen in combination with gemcitabine for...

read more
Ground-Breaking Gene Therapy for Hunter Syndrome

Ground-Breaking Gene Therapy for Hunter Syndrome

Miraculous Progress for 3-Year-Old After Ground-Breaking Gene Therapy for Hunter Syndrome A three-year-old boy, Oliver Chu, has astounded doctors after becoming the first person in the world with Hunter syndrome also called MPS II to receive a pioneering gene therapy....

read more
US Scientists Create Human Embryos from Skin Cells

US Scientists Create Human Embryos from Skin Cells

In a ground breaking advance in reproductive biology, researchers in the United States have for the first time created early-stage human embryos by converting DNA from skin cells into functional eggs and then fertilising them with sperm. Though still at an...

read more